Scholarlink

<p>Chronic kidney disease (CKD) is anticipated to be the fifth cause of global death by 2040 due to the lack of therapeutic tools currently. <i>Lactobacillus paracasei</i> (<i>L. paracasei</i>) isolated from artisanal fermented beverages has been implicated to have health-promoting properties. This study was designed to investigate the effects of <i>L. paracasei</i> on the mechanisms underlying renal injury regulation during CKD. A mouse CKD model was developed by 5/6 nephrectomy, and a fibrotic cell model was induced on human kidney-2 (HK-2) cells using TGF-β1. <i>L. paracasei</i> alleviated renal injury in CKD mice and TGF-β1-induced inflammatory and fibrotic injury in HK-2 cells. <i>L. paracasei</i> exerted in vitro and in vivo benefits by inducing lysine-specific demethylase 3A (KDM3A), and the knockdown of KDM3A markedly attenuated the therapeutic benefit of <i>L. paracasei</i>. KDM3A activated vacuole membrane protein 1 (VMP1) by removing the H3K9me1/2 modification on its promoter. <i>L. paracasei</i> activated autophagy to mitigate renal damage, which was compromised by the autophagy inhibitor 3-MA, allowing renal damage to intensify. Taken together, <i>L. paracasei</i> activates KDM3A expression and further activates VMP1 expression by removing inhibitory H3K9me1/2 modification on the VMP1 promoter to alleviate CKD by activating autophagy in renal tubular epithelial cells.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Lactobacillus paracasei Activates the KDM3A/VAMP1 Axis to Induce Autophagy in Renal Tubular Epithelial Cells in Chronic Kidney Disease

  • 期刊论文

  • 发表日期：

    2025年3月20日

查看全文
  • Chieh-lun Yang,
  • Wen-hsing Yang,
  • Zhanhui Gao,
  • Sijia Liu,
  • Wei Wei,
  • Fenfen Duan,
  • Haiyan Chen,
  • Jizhuang Lou

摘要

Chronic kidney disease (CKD) is anticipated to be the fifth cause of global death by 2040 due to the lack of therapeutic tools currently. Lactobacillus paracasei (L. paracasei) isolated from artisanal fermented beverages has been implicated to have health-promoting properties. This study was designed to investigate the effects of L. paracasei on the mechanisms underlying renal injury regulation during CKD. A mouse CKD model was developed by 5/6 nephrectomy, and a fibrotic cell model was induced on human kidney-2 (HK-2) cells using TGF-β1. L. paracasei alleviated renal injury in CKD mice and TGF-β1-induced inflammatory and fibrotic injury in HK-2 cells. L. paracasei exerted in vitro and in vivo benefits by inducing lysine-specific demethylase 3A (KDM3A), and the knockdown of KDM3A markedly attenuated the therapeutic benefit of L. paracasei. KDM3A activated vacuole membrane protein 1 (VMP1) by removing the H3K9me1/2 modification on its promoter. L. paracasei activated autophagy to mitigate renal damage, which was compromised by the autophagy inhibitor 3-MA, allowing renal damage to intensify. Taken together, L. paracasei activates KDM3A expression and further activates VMP1 expression by removing inhibitory H3K9me1/2 modification on the VMP1 promoter to alleviate CKD by activating autophagy in renal tubular epithelial cells.